- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:42 | Oncorus raises £65.5m funding to advance oncolytic virus therapies | ||
| 12:42 | Mundipharma announces licence extension submission for Invokana and Vokanamet to EMA | ||
| 10:42 | GSK submits first regulatory application for daprodustat in Japan | ||
| 09:42 | Pfizer to invest £411m in new US gene therapy manufacturing facility | ||
| Mi | Bayer to offload animal health business to Elanco for £6.27bn | ||
| Mi | Graybug Vision secures £66m to advance retina and glaucoma clinical programs | ||
| Mi | FDA accepts new drug application for elexacaftor , tezacaftor and ivacaftor combination treatment | ||
| Mi | AstraZeneca's Farxiga meets primary endpoint in phase III heart failure study | ||
| Di | Knopp begins phase 2 trial for oral dexpramipexole in eosinophilic asthma | ||
| Di | FDA grants fast track status to Moderna's Zika vaccine | ||
| Di | Angel-funded Siamab completes £166m exit with large commercial-stage biopharma | ||
| Mo | Xynomic Research Institute successfully designs series of potent RET kinase inhibitors | ||
| Mo | AbbVie receives FDA approval of RINVOQ for moderate to severe rheumatoid arthritis | ||
| Mo | Celgene gets FDA approval for myelofibrosis treatment Inrebic | ||
| Fr | European Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis | ||
| Fr | GeneCentric Therapeutics acquires Select ImmunoGenomics | ||
| Fr | Roche gets FDA nod for Rozlytrek to treat ROS1-positive NSCLC | ||
| 15.08. | Lynparza plus bevacizumab meets primary endpoint in PAOLA-1 trial | ||
| 14.08. | Lilly announces superiority of Taltz versus TREMFYA in IXORA-R trial | ||
| 14.08. | Landos Biopharma completes £49.7m series B financing | ||
| 14.08. | Janssen gets EC approval for two new indications of Imbruvica | ||
| 13.08. | Kedrion Biopharma announces enrollment of first patient in CARES10 trial | ||
| 13.08. | Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares | ||
| 13.08. | Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m | ||
| 12.08. | Ascletis opens Clinical Development Shanghai Center |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
